Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. | Cell Rep | 2023 | 37742191 | PubTator, text mining | PubMed |
| Bladder cancer course, four genetic high-risk variants, and histopathological findings. | EXCLI J | 2023 | 37720238 | PubTator, text mining | PubMed |
| Mechanism of spindle assembly regulated by the human oocyte microtubule organizing centre in human oocytes. | Clin Transl Med | 2023 | 37715449 | PubTator, text mining | PubMed |
| Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs. | J Transl Med | 2023 | 37715207 | PubTator, text mining | PubMed |
| Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial. | Nat Med | 2023 | 37710001 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Global impact of somatic structural variation on the cancer proteome. | Nat Commun | 2023 | 37704602 | PubTator, text mining | PubMed |
| Recurrent Glioblastoma: A Review of the Treatment Options. | Cancers (Basel) | 2023 | 37686553 | PubTator, text mining | PubMed |
| Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy. | Front Immunol | 2023 | 37675102 | PubTator, text mining | PubMed |
| Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature. | Int J Endocrinol Metab | 2023 | 37662645 | PubTator, text mining | PubMed |
| The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology. | Sci Rep | 2023 | 37660159 | PubTator, text mining | PubMed |
| The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. | Mol Cancer | 2023 | 37649123 | PubTator, text mining | PubMed |
| SFyNCS detects oncogenic fusions involving non-coding sequences in cancer. | Nucleic Acids Res | 2023 | 37638762 | PubTator, text mining | PubMed |
| Systematic investigation of the homology sequences around the human fusion gene breakpoints in pan-cancer - bioinformatics study for a potential link to MMEJ. | Brief Bioinform | 2023 | 37635381 | PubTator, text mining | PubMed |
The identification of distinct protective and susceptibility mechanisms for hip osteoarthritis: findings from a genome-wide association study meta-analysis of minimum joint space width and Mendelian randomisation cluster analyses. | EBioMedicine | 2023 | 37619450 | PubTator, text mining | PubMed |
| Integrated longitudinal circulating tumor DNA profiling predicts immunotherapy response of metastatic urothelial carcinoma in the POLARIS-03 trial. | J Pathol | 2023 | 37584165 | PubTator, text mining | PubMed |
| Multi-Target Neural Differentiation (MTND) Therapeutic Cocktail to Suppress Brain Tumor. | Int J Mol Sci | 2023 | 37569705 | PubTator, text mining | PubMed |
| Expression of genes regulating cell division in porcine follicular granulosa cells. | Cell Div | 2023 | 37550786 | PubTator, text mining | PubMed |
| Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis. | Cancer Med | 2023 | 37537783 | PubTator, text mining | PubMed |
| Molecular classification of urothelial bladder carcinoma. | Mol Biol Rep | 2023 | 37525073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers?page=9